Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells

Experimental Cell Research

Volumn 248, Issue 1, 1999, Pages 87-96

  Hsu, Shih Lan ^a   Chen, Mei Chih ^b   Chou, Ya Hui ^a   Hwang, Guang Yuh ^b   Yin, Sui Chu ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Bax; P21CIP2 Waf1; P34cdc2; Retinoic acid

Indexed keywords

PROTEIN BAX; PROTEIN KINASE; PROTEIN P21; PROTEIN P53; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL CYCLE; DRUG MECHANISM; GENE ACTIVATION; GENE INDUCTION; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; MITOSIS INDEX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0033541438     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4397     Document Type: Article

References (48)

1. Majno G., Joris I. Apoptosis, oncosis, and necrosis - An overview of cell death. Am. J. Pathol. 146:1995;3-19.
2. Barry M. A., Behnke C. A., Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40:1990;2353-2362.
3. Green D. R., Bissonnette R. P., Cotter T. G. Apoptosis and cancer. Principles Pract. Oncol. 8:1994;1-14.
4. Lotan R. Retinoids in cancer chemoprevention. FASEB J. 10:1996;1031-1039.
5. Chomienne C., Fenaux P., Gegos L. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J. 10:1996;1025-1030.
6. Smith M., Parkinson D., Cheson B., Friedman M. Retinoids in cancer therapy. J. Clin. Oncol. 10:1992;839-864.
7. Hong W., Lippman S., Itri L., Karp D., Lee J., Byers R., Schantz S., Kramer A., Lotan R., Peters L., Dimery I., Brown B., Goeppert H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323:1990;795-801.
8. Kraemer K., DiGiovanna J., Moshell A., Tarone R., Pock G. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N. Engl. J. Med. 318:1988;1633-1637.
9. Piacentini M., Annicchiarico-Petruzzelli M., Oliverio S., Piredda L., Biedler J. L., Melino G. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosis. Int. J. Cancer. 52:1992;271-278.
10. Lotan R. Retinoids and apoptosis: Implications for cancer chemoprevention and therapy. J. Natl. Cancer Inst. 87:1995;1655-1657.
11. Evan G. I., Wyllie A. H., Gilbert C. S., Littlewood K. H., Land H., Brooks M., Waters C. M., Penn L. Z., Hancock D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
12. Askew D. S., Ashmun R. A., Simmons B. C., Cleveland J. L. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. 6:1991;1915-1922.
13. Shi Y., Glynn J. M., Guilbert L. J., Cotter T. G., Bissonnette R. P., Green D. R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 257:1992;212-214.
14. Lowe S. W., Schmitt E. M., Smith S. W., Osborne B. A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
15. Meikrantz W., Gisselbrecht S., Tam S. W., Schlegel R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl. Acad. Sci. USA. 91:1994;3754-3758.
16. Gao C. Y., Zelenka P. S. Induction of cyclin B and H1 kinase activity in apoptotic PC12 cells. Exp. Cell Res. 219:1995;612-618.
17. Kranenburg O., van der Eb A. J., Zantema A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J. 15:1996;46-54.
18. Wang Q., Worland P. J., Clark J. L., Carlson B. A., Sausville E. A. Apoptosis in 7-hydroxystaurospurine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. Cell Growth Differ. 6:1995;927-936.
19. Donaldson K. L., Goolsby G., Kiener P. A., Wahl A. F. Activation of p34cdc2 coincident with Taxol-induced apoptosis. Cell Growth Differ. 5:1994;1041-1050.
20. El-Deiry W. S., Harper J. W., O'Conner P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y., Wiman K. G., Mercer W. E., Kastan M. B., Kohn K. W., Elledge S. J., Kinzler K. W., Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
21. 2. Cancer Res. 56:1996;475-479.
22. CIP2/Waf1. Oncogene. 11:1995;2311-2316.
23. Hsu S. L., Wu W. S., Tyan Y. S., Chou C. K. Retinoic acid-induced apoptosis is prevented by serum albumin, and enhanced by Lipiodol in human hepatoma Hep3B cells. Cancer Lett. 129:1998;205-214.
24. Rubin L. L., Philpott K. L., Brooks S. F. The cell cycle and cell death. Curr. Biol. 3:1993;391-394.
25. Heintz N. Cell death and the cell cycle: A relationship between transformation and neurodegeneration? Trends Biochem. Sci. 18:1993;157-159.
26. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
27. Poluha W., Poluha D. K., Chang B., Crosbie N. E., Schonhoff C. M., Kilpatrick D. L., Ross A. H. The cyclin-dependent kinase inhibitor p21WAF1 is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol. 16:1996;1335-1341.
28. Onishi T., Zhang W. Y., Cao X., Hruska K. The mitogenic effect of parathyroid hormone is associated with E2F-dependent activation of cyclin-dependent kinase 1 (cdc2) in osteoblast precursors. J. Bone Miner. Res. 12:1997;1596-1605.
29. Cordon-Cardo C. Mutation of cell cycle regulators - Biological and clinical implications for human neoplasia. Am. J. Pathol. 147:1995;545-560.
30. Shi L., Nishioka W. K., Th'ng J., Bradbury E. M., Lichfield D. W., Greenberg A. H. Premature p34cdc2 activation required for apoptosis. Science. 263:1994;1143-1145.
31. Vesely J., Havlicek L., Strnad M., Blow J. J., Donella-Dean A., Pinna L., Letham D. S., Kato J., Detivaud L., Leclerc S., Meijer L. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224:1994;771-786.
32. Farshid M., Tabor E. Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell line. J. Med. Virol. 38:1992;235-239.
33. Miyashita T., Reed J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
34. Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
35. Agarwal M. L., Agarwal A., Taylor W. R., Stark G. R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA. 92:1995;8493-8497.
36. Waldman T., Kinzler K. W., Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55:1995;5187-5190.
37. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. T. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
38. Attardi L. D., Lowe S. W., Brugarolas J., Jacks T. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15:1996;3693-3701.
39. WAF1/CIP1. Oncogene. 11:1995;1899-1905.
40. Poluha W., Poluha D. K., Chang B., Crosbie N. E., Schonhoff C. M., Kilpatrick D. L., Ross A. H. The cyclin-dependent kinase inhibitor p21 WAF1 is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol. 16:1996;1335-1341.
41. Ucker D. S. Death by suicide: One way to go in mammalian cellular development. New Biol. 3:1991;103-109.
42. Ucker D. S., Obermiller P. S., Eckhart W., Apgar J. P., Berger N. A., Meyers J. Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol. Cell Biol. 12:1992;3060-3069.
43. Lazebnik Y. A., Cole S., Cooke C. A., Nelson W. G., Earnshaw W. C. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: A model system for analysis of the active phase of apoptosis. J. Cell Biol. 123:1993;7-22.
44. Sen S., D'Incalci M. Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett. 307:1992;122-127.
45. Kung A. L., Zetterberg A., Sherwood S. W., Schimke R. T. Cytotoxic effects of cell cycle phase specific agents: Result of cell cycle perturbation. Cancer Res. 50:1990;7307-7317.
46. Shimizu T., O'Connor P. M., Kohn K. W., Pommier Y. Unscheduled activation of cyclin B1/cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res. 55:1995;228-231.
47. Yao S. L., Mckenna K. A., Sharkis S. J., Bedi A. Requirement of p34cdc2 kinases for apoptosis mediated by the Fas/Apo-1 receptor and interleukin 1β-converting enzyme-related protease. Cancer Res. 56:1996;4551-4555.
48. Zhang H., Hannon G. J., Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1994;1750-1758.